Evidence map›Paper›PMID 24494197›Full record

ArticleRedox biology2014

Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity.

William Dott, Pratibha Mistry, Jayne Wright, Kelvin Cain, Karl E Herbert

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Metabolic Profiling of DistinctInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Control of NADThe EMBO journal · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

William DottDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester LE3 9QP, UK.
Pratibha MistrySyngenta Ltd., Jealott's Hill, UK.
Jayne WrightSyngenta Ltd., Jealott's Hill, UK.
Kelvin CainMRC Toxicology Unit, University of Leicester, Leicester, UK.
Karl E HerbertDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester LE3 9QP, UK.
Syngenta (United Kingdom) · GBUniversity of Leicester · GBGlenfield Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial toxicity is increasingly being implicated as a contributing factor to many xenobiotic-induced organ toxicities, including skeletal muscle toxicity. This has necessitated the need for predictive in vitro models that are able to sensitively detect mitochondrial toxicity of chemical entities early in the research and development process. One such cell model involves substituting galactose for glucose in the culture media. Since cells cultured in galactose are unable to generate sufficient ATP from glycolysis they are forced to rely on mitochondrial oxidative phosphorylation for ATP generation and consequently are more sensitive to mitochondrial perturbation than cells grown in glucose. The aim of this study was to characterise cellular growth, bioenergetics and mitochondrial toxicity of the L6 rat skeletal muscle cell line cultured in either high glucose or galactose media. L6 myoblasts proliferated more slowly when cultured in galactose media, although they maintained similar levels of ATP. Galactose cultured L6 cells were significantly more sensitive to classical mitochondrial toxicants than glucose-cultured cells, confirming the cells had adapted to galactose media. Analysis of bioenergetic function with the XF Seahorse extracellular flux analyser demonstrated that oxygen consumption rate (OCR) was significantly increased whereas extracellular acidification rate (ECAR), a measure of glycolysis, was decreased in cells grown in galactose. Mitochondria operated closer to state 3 respiration and had a lower mitochondrial membrane potential and basal mitochondrial O2 (•-) level compared to cells in the glucose model. An antimycin A (AA) dose response revealed that there was no difference in the sensitivity of OCR to AA inhibition between glucose and galactose cells. Importantly, cells in glucose were able to up-regulate glycolysis, while galactose cells were not. These results confirm that L6 cells are able to adapt to growth in a galactose media model and are consequently more susceptible to mitochondrial toxicants.

Indexed as

Adenosine TriphosphateAnimalsAntimycin ACell Culture TechniquesCell LineEnergy MetabolismGalactoseGlucoseHep G2 CellsHumansMitochondria, MuscleModels, BiologicalMuscle, SkeletalOxygen ConsumptionRatsAdenosine TriphosphateAntimycin AGalactoseGlucoseAA, antimycin AANT, adenine nucleotide translocaseCPD, cumulative population doublingsECAR, extracellular acidification rateETC, electron transport chainExtracellular flux analysisFCCP, Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazoneFSC, forward scatterGalactoseMitochondriaO2•–, superoxideOCR, oxygen consumption rateOligo, oligomycinOXPHOS, oxidative phosphorylationPD, population doublingsPPP, pentose phosphate pathwayRCR, respiratory control ratioSkeletal muscle toxicitySSC, side scatterTCA, tricarboxylic acid cycleUCPs, uncoupling proteinsXF, extracellular flux

Identifiers

PMID24494197
PMCPMC3909783
OpenAlexW2065729561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.